StockSelector.com
  Research, Select, & Monitor Sunday, October 20, 2019 5:53:27 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Neos Therapeutics, Inc.$1.39($.03)(2.11%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Neos Therapeutics, Inc. has an overall rank of 6121 out of 7004 stocks based on 7 positive rankings and 9 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for Neos Therapeutics is $89.37. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Neos Therapeutics is ranked 31.
Historic Revenue Growth
Neos Therapeutics rank is 44
Positive MACD Cross
Neos Therapeutics rank is 149
Up EPS Surprise
Neos Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Low Put/Call
Neos Therapeutics has a low Put/Call ratio of 0.27 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Neos Therapeutics is ranked 640.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Neos Therapeutics is ranked 840.
Price-to-Sales
Neos Therapeutics rank is 1798
Negative Rankings
Negative ROE
Neos Therapeutics rank is 49
Debt-to-Equity
Neos Therapeutics rank is 155
Price-to-Book
Neos Therapeutics rank is 447
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Neos Therapeutics is ranked 487.
Negative ROA
Neos Therapeutics rank is 575
Negative Net Margin
Neos Therapeutics rank is 591
High vPut/Call
Neos Therapeutics has a high Put/Call ratio of 0.95 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Neos Therapeutics is ranked 1322.
10 Day Loss
Neos Therapeutics rank is 1424
90 Day Loss
Neos Therapeutics rank is 1939







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.